Browsed by
Tag: european

Arena Pharmaceuticals’ Presence at United European Gastroenterology Week Strengthens Ongoing Commitment to the Gastrointestinal Disease Community

Arena Pharmaceuticals’ Presence at United European Gastroenterology Week Strengthens Ongoing Commitment to the Gastrointestinal Disease Community

SAN DIEGO, Oct. 9, 2020 /PRNewswire/ — Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will present new data from the Phase 2 OASIS trial and its open-label extension for its investigative drug candidate etrasimod, a next-generation, once-daily, oral, highly selective sphingosine 1-phosphate (S1P) receptor modulator, in patients with moderately to severely active ulcerative colitis (UC) at the 26th Annual United European Gastroenterology (UEG) Week. Arena will also present preclinical data for olorinab, a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2 (CB2), in development for the treatment of visceral pain in gastrointestinal (GI) diseases. UEG Week is taking place virtually October 11-13, 2020.

Arena Sponsored Symposium Details: 
Title: Opening the Door to Emerging Investigational Treatments in Ulcerative Colitis: What Awaits Us?
Intended Audience: This symposium is designed for non-US healthcare professionals and is not affiliated with UEGW
Speakers: William Sandborn, MD (Chair), Professor Silvio Danese, Remo Panaccione, MD, FRCPC
Day/Time: Monday, October 12 at 17:30 CET

Presentation Details:
Title: Early and Durable Symptom Control in Patients with Moderately to Severely Active Ulcerative Colitis Treated with Etrasimod in the Randomised, Double Blind, Placebo Controlled, Phase 2 OASIS Trial and Open Label Extension
Day/Time: Tuesday, October 13, 2020, from 15:00-16:00 CET
ePoster: P0481

Title: Expression of Cannabinoid Receptors and the Effect of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, on Visceral Hypersensitivity in Rodent Models of Irritable Bowel Syndrome and Inflammatory Bowel Disease 
Day/Time: Sunday, October 11, 2020, 18:00-19:00 CET    
Oral presentation: OP058    

Title: The Incremental Increasing Rate of Thromboembolic Events in Patients with Inflammatory Bowel Disease Compared to Patients Without Autoimmune Disorder   
Event: Virtual poster exhibition
ePoster: P0377                    

About Etrasimod
Etrasimod (APD334) is a once-daily, oral, highly selective sphingosine 1-phosphate (S1P) receptor modulator, discovered by Arena, designed

Read the rest
European stocks climb despite slowing economic recovery

European stocks climb despite slowing economic recovery

European stocks continued their ascent on Friday morning despite sustained uncertainty about the continent’s economic recovery and rising coronavirus infections.

The region-wide Stoxx 600 was up 0.2 per cent by mid-morning while London’s FTSE 100 advanced 0.6 per cent and France’s Cac 40 edged up 0.3 per cent. European equities also advanced on Thursday, with major bourses trading around their highest level in almost three weeks.

The moves higher came despite indications that the continent’s economic recovery had slowed to a crawl. Data released on Friday showed that UK economic output grew slower than expected in August, rising 2.1 per cent month-on-month compared with expectations by analysts polled by Reuters for a 4.6 per cent increase. In France, industrial production rose 1.3 per cent in August, according to Insee, below expectations for a 1.7 per cent increase.

UK gross domestic product was nearly 10 per cent below its pre-Covid-19 February level despite the loosening of coronavirus curbs, “underlining that the recovery has not been V-shaped”, said Samuel Tombs, chief UK economist at Pantheon Macroeconomics.

James Smith, developed markets economist at ING, said the UK’s recovery “looks set to stall in the fourth quarter as fresh virus measures loom” while infections rise.

In the Asia-Pacific region, China’s onshore renminbi, which has not moved for six trading days thanks to the lengthy National Day holiday, rose as much as 1.2 per cent on Friday to Rmb6.7091 per dollar. That marked the currency’s biggest intraday increase against the greenback since February 2016.

The less-regulated offshore renminbi, which traded throughout most of the recent holiday, climbed 0.6 per cent to Rmb6.6976.

Mounting expectations of a win for Democratic candidate Joe Biden in November’s US presidential election helped boost sentiment towards China’s currency.

China’s onshore stock market was also bolstered by signs that the

Read the rest
U.S. imposes new Iran sanctions that may spook European banks

U.S. imposes new Iran sanctions that may spook European banks

WASHINGTON (Reuters) – The United States on Thursday slapped fresh sanctions on Iran’s financial sector, targeting 18 banks in an effort to further choke off Iranian revenues as Washington ramps up pressure on Tehran weeks ahead of the U.S. election.

FILE PHOTO: A staff member removes the Iranian flag from the stage after a group picture with foreign ministers and representatives of the U.S., Iran, China, Russia, Britain, Germany, France and the European Union during the Iran nuclear talks at the Vienna International Center in Vienna, Austria July 14, 2015. REUTERS/Carlos Barria

The move freezes any U.S. assets of those blacklisted and generally bars Americans from dealing with them, while extending secondary sanctions to those who do business with them. This means foreign banks risk losing access to the U.S. market and financial system.

The Treasury Department said in a statement the prohibitions did not apply to transactions to sell agricultural commodities, food, medicine or medical devices to Iran, saying it understood the Iranian people’s need for humanitarian goods.

However, analysts said the secondary sanctions may further deter European and other foreign banks from working with Iran, even for permitted humanitarian transactions.

“It’s like a punch in the face to the Europeans, who have gone out of their way to indicate to the Americans that they view it as being extremely threatening to humanitarian assistance or humanitarian trade going to Iran,” said Elizabeth Rosenberg of the Center for a New American Security think tank.

“They also want … to make it very difficult for any future president to be able to unwind these measures and engage in nuclear diplomacy,” Rosenberg added, alluding to the possibility that Democratic former Vice President Joe Biden could defeat Republican President Donald Trump in the Nov. 3 U.S. election.


Read the rest